Cardiovascular Gastro/Intestinal Gynecology Neuro Orthopedics Ophthalmology Pulmonary Urology Vascular

Cotherix is developing a therapy for COPD, a chronic condition afflicting 17 million people in the U.S. Spray formed this company with technology licensed from Columbia University. Cotherix (CTRX:NASDAQ) completed itÕs IPO on October 15, 2004. PneumRx is a company developing a line of products in the field of Interventional Pulmonology. The devices are targeting the large markets of Lung Cancer Diagnosis and Emphysema Therapy.